Place: Switzerland Innovation Park Basel Area AG, Gewerbestrasse 24, 4123 Allschwil



European - Chinese Pharma Partnering

Key topics of the event:
Successful pharma licensing strategies to China, experience and lessons learned

Views on value maximizing partnerships from both European and Chinese perspectives

Challenges and rewards of cross-cultural partnering

Opportunities to meet with some of China’s leading pharma and innovative biotech companies

When: 12.10.2018, 08:45 - 16:00
Where: Switzerland Innovation Park Basel Area, Gewerbestrasse 24, 4123 Allschwil, Switzerland
​Who should participate?

Business development executives from European pharma and biotech companies seeking to work with partners from China to expand into the Chinese market.

​​Participants from China:
The following companies have confirmed their participation (expect 10 Chinese companies in total)

  • Sihuan Pharmaceutical
  • Humanwell Healthcare
  • Zhejiang Hisun Pharmaceutical
  • Konruns Pharmaceutical
  • Changjiang Runfa Medicine
  • EnnovaBio
  • Junshi Biosciences
  • Space Peptides

Registration fee of EUR 200. Register here.


Part 1 - The European perspective on challenges and opportunities of partnering

8:45 Hans Peter Hasler, Chairman HBM Healthcare Investments: Venturing
into uncharted waters. Lessons learned
9:00 Jean-Marc Sequier, Global Head of Divestments, Out-licensing at Novartis
Pharma: Out-partnering and divestment activities at Novartis
9:30 Peter L. Dolan, Senior Director Strategy and Business Development at
Sanofi: Successful pharma licensing strategies
10:00 Laurenz Kellenberger, Chief Scientific Officer at Basilea Pharmaceuticals:
SME perspective on licensing/distribution to Chinese companies
10:30 Coffee break


Part 2 - The Chinese perspective on partnering 

11:00 Chris Lu, CEO at Laekna Therapeutics: Chinese deal perspective
11:30 Jianyong Shou, Chief Scientific Officer at EnnovaBio: Value created partnership
in the current Chinese drug discovery and development ecosystem
Innovative Chinese Biotech perspective
12:00 Panel discussion: lessons learned, challenges and future trends
Jörg Kazenwadel, Head of R&D Out-licensing at Roche Pharma
Huaizhong Hu, Head of R&D at Konruns Pharmaceutical
12:30 Networking lunch


Part 3 - Company presentation session 

13:30 Company presentations
16:00 End of event



Cookies uses cookies to ensure you get the best service on our website.
By continuing to browse the site, you are agreeing to the use of cookies.